Diagnosis and management of non‐alcoholic fatty liver disease and related metabolic disorders: Consensus statement from the
, 2013 Xin Gao, Jian‐Gao Fan
openalex +1 more source
Comparison of performance, fatty acid composition, enzymes and gene expression between overfed Xupu geese with large and small liver [PDF]
, 2021 Xu Liu +5 more
openalex +1 more source
Reply to correspondence on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis” [PDF]
Clinical and Molecular HepatologyJing Zeng, Jian-Gao Fan
doaj +1 more source
MAFLD - a new approach to fatty liver disease
Journal of Education, Health and SportFatty liver disease associated with metabolic dysfunction (MAFLD) is a term introduced in 2020 to refer to fatty liver disease associated with systemic metabolic dysregulation. The name change from nonalcoholic fatty liver disease (NAFLD) to fatty liver
Borys Łozowski +10 more
doaj +1 more source
Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine [PDF]
, 2019 Annette Brandt +8 more
openalex +1 more source
Relationship of urinary liver-type fatty acid-binding protein with cardiovascular risk factors in the Japanese population without chronic kidney disease: Sasayama study [PDF]
, 2021 Yoshimi Kubota +7 more
openalex +1 more source
A Nutrigenomic Approach to Non-Alcoholic Fatty Liver Disease [PDF]
, 2017 Paola Dongiovanni, Luca Valenti
openalex +1 more source
Inflammatory and immune changes and treatment in patients with fatty liver disease
, 2016 Baoge Qu
openalex +1 more source